BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Monday, January 19, 2026
Home » Topics » Briefs

Briefs
Briefs RSS Feed RSS

Other news to note for Nov. 5, 2020

Nov. 5, 2020
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Avidea, Cellarity, Crescita, Cymabay, Egenesis, Gilead Metriopharm, Neoleukin, Oncoceutics, Ose, Proteonic, Qualigen, Rexahn, Saniona, Wuxi Apptec, Y-mabs.
Read More

In the clinic for Nov. 5, 2020

Nov. 5, 2020
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Abbvie, Actinium, Acurx, Agenus, Arch, Aveo, Boehringer, Cellectar, Cytomx, Eusa, Genmab, Madrigal, Neurorx, Novartis, Novo Nordisk, Radnor, Rhythm, Rubius, Synlogic.
Read More

Financings for Nov. 5, 2020

Nov. 5, 2020
Biopharmas raising money in public or private financings, including: Allarity, Lilly, Outlook, Promis, Protomer, Stealth.
Read More

Earnings for Nov. 5, 2020

Nov. 5, 2020
Quarterly snapshots from biopharma companies with marketed products, including: Acceleron, Agios, Amarin, Amicus, Clovis, Incyte, Regeneron.
Read More

Appointments and advancements for Nov. 5, 2020

Nov. 5, 2020
New hires and promotions in the biopharma industry, including: Agenus, Arcutis, Biodelivery Sciences, Calcimedica, Plus, Tacalyx, Vectivbio, Xphyto.
Read More

Regulatory actions for Nov. 4, 2020

Nov. 4, 2020
Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Sensetime.
Read More

Other news to note for Nov. 4, 2020

Nov. 4, 2020
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Applied UV, Axsome Therapeutics, Clinical Laserthermia Systems, Digirad, Electromedical Technologies, Energetic Wellness School of Naturopathy, The Feinstein Institutes for Medical Research, Mimedx, Novan, Ontrak, Stryker, Thermo Fisher Scientific, Toyoda Gosei, Wright Medical Group.
Read More

In the clinic for Nov. 4, 2020

Nov. 4, 2020
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Mauna Kea Technologies, Truvian.
Read More

Financings for Nov. 4, 2020

Nov. 4, 2020
Med-tech firms raising money in public or private financings, including: Evogene.
Read More

Appointments and advancements for Nov. 4, 2020

Nov. 4, 2020
New hires and promotions in the med-tech industry, including: Agility Health.
Read More
Previous 1 2 … 1430 1431 1432 1433 1434 1435 1436 1437 1438 … 1738 1739 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for Jan 16, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for Jan. 16, 2026.
  • Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal

    BioWorld
    With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
  • Illustration of human body surrounded by DNA, cell and drug icons

    Cell/gene therapy sector now sustainable; China competition mounting

    BioWorld
    There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
  • Businesswoman pressing dollar sign on touchscreen

    JPM 2026: Year kicks off with biopharma Q4 revenue and guidance

    BioWorld
    It was a battle of the companies with drugs for transthyretin-mediated amyloidosis on the first day of the J.P. Morgan 2026 Healthcare Conference with Alnylam...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • NME Digest
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing